Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
Go back to Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights| (NASDAQ: XERS) | Delayed: 8.73 -0.07 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.80 | 52 Week High | $ | |||
| Open | $8.90 | 52 Week Low | $ | |||
| Day High | $8.97 | P/E | N/A | |||
| Day Low | $8.64 | EPS | $ | |||
| Volume | 1,688,383 | |||||

